Activity of cilofungin (LY 121019), a new lipopeptide antibiotic, on the cell wall and cytoplasmic membrane of<i>Candida albicans</i>. Structural modifications in scanning and transmission electron microscopy
E. Drouhet(Institut Pasteur), M.C. Prévost(Institut Pasteur), M. Lesourd(Institut Pasteur), L. Improvisi(Institut Pasteur), B. Dupont(Délégation Paris 5)
Cited by 12
Related Papers
Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007
|Clinical Microbiology and Infection|2011|752
Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections
|Clinical Infectious Diseases|2003|680
Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria
|Clinical Infectious Diseases|2008|469
Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children
|The Pediatric Infectious Disease Journal|2002|436